Telecom Healthcare Sector

Vivos

Market Cap: US$61.6m

A radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States.

NeueHealth

Market Cap: US$61.3m

A healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States.

Verrica Pharmaceuticals

Market Cap: US$61.3m

A dermatology therapeutics company, engages in the development and sale of medications for the treatment of skin diseases in the United States.

Vivani Medical

Market Cap: US$61.0m

A clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases.

United Health Products

Market Cap: US$60.7m

Develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States.

Quipt Home Medical

Market Cap: CA$84.7m

Through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States.

SkinBioTherapeutics

Market Cap: UK£45.4m

A life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, and internationally.

Surrozen

Market Cap: US$60.3m

A biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair.

Cyberfuels Holding

Market Cap: US$59.9m

Operates as an energy and healthcare company in the United States.

Argenica Therapeutics

Market Cap: AU$93.5m

A biotechnology company, engages in the research and development of neuroprotective therapeutic drug in Australia.

Retrieve Medical Holdings

Market Cap: US$59.2m

Develops software solutions related to data mining, clinical decision support, natural language processing, and algorithmic testing for analyzing patient’s accumulated medical records and lab results in medical center emergency departments.

Singular Health Group

Market Cap: AU$92.3m

A medical technology company, engages in the development and commercialization of volumetric rendering platform (VRP) and software development in Australia.

IceCure Medical

Market Cap: US$58.8m

A commercial stage medical device company, researches, develops, and markets cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally.

Outlook Therapeutics

Market Cap: US$58.7m

Operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications.

INSPECS Group

Market Cap: UK£44.2m

Designs, produces, sells, markets, and distributes fashion eyewear, lenses, and OEM products in the United Kingdom, Europe, North America, South America, Asia, Africa, and Australia.

Medinotec

Market Cap: US$58.7m

Engages in the research and development, production, and sale of medical devices in South Africa, the United States, and internationally.

Alterity Therapeutics

Market Cap: AU$91.3m

Engages in the research and development of therapeutic drugs to treat Alzheimer’s disease, Huntington disease, Parkinson’s disease, and other neurological disorders in Australia.

Skye Bioscience

Market Cap: US$57.9m

A clinical stage biopharmaceutical company, focuses on developing molecules that modulate G protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases.

Mach7 Technologies

Market Cap: AU$90.1m

Provides enterprise imaging data sharing, storage, and interoperability for healthcare enterprises in North America, the Asia Pacific, the Middle East, Europe, and internationally.

P3 Health Partners

Market Cap: US$57.4m

A patient-centered and physician-led population health management company, provides superior care services in the United States.

Vicapsys Life Sciences

Market Cap: US$57.3m

Focuses on the development and commercialization of VICAPSYN, a proprietary product.

Biomea Fusion

Market Cap: US$57.1m

A clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases.

Immix Biopharma

Market Cap: US$57.1m

A clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia.

Repare Therapeutics

Market Cap: US$57.0m

A clinical-stage precision oncology company, engages in the discovery and development of therapeutics in Switzerland and the United States.

Serina Therapeutics

Market Cap: US$56.5m

A biotechnology company, develops drugs to treat neurological diseases and pain.

Cytosorbents

Market Cap: US$56.3m

Engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology in the United States, Germany, and internationally.

ECO Animal Health Group

Market Cap: UK£42.3m

Develops, registers, and markets pharmaceutical products for animals worldwide.

Gain Therapeutics

Market Cap: US$55.9m

A biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas in Switzerland, Spain, the United States, and Australia.

Gemina Laboratories

Market Cap: CA$77.6m

A biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada.

Renovaro

Market Cap: US$55.4m

A pre-clinical stage biotechnology company, engages in the development of pharmaceutical and biological products for the treatment of cancer and HIV in the United States and the Netherlands.

Onco-Innovations

Market Cap: CA$77.2m

A pre-clinical stage biotechnology company, develops drug candidates for cancer treatments.

AMJ Global Technology

Market Cap: US$55.1m

Engages in developing mobile software products in the United States.

vTv Therapeutics

Market Cap: US$54.9m

A clinical stage biopharmaceutical company, focuses on the development of orally administered treatments for metabolic and inflammatory diseases.

Cue Biopharma

Market Cap: US$54.6m

A clinical-stage biopharmaceutical company, develops a novel class of injectable therapeutics to selectively engage and modulate targeted, disease relevant T cells in the United States.

MAIA Biotechnology

Market Cap: US$54.6m

MAIA Biotechnology, Inc., together with its subsidiaries, immuno-oncology company, focuses on the development and commercialization of drugs with novel mechanisms of action that are intended to improve and extend the lives of people with cancer.

Biomind Labs

Market Cap: US$54.3m

A biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions.